Investors
List of the current and past investors into Cabrellis Pharmaceuticals Corp with their respective financial instruments.| Investor | Profile | Country | Phone | Round | |||
|---|---|---|---|---|---|---|---|
|
Domain Associates LLC | Venture capital firm focused on life sciences companies. | United States | +1 (858) 480-2400 | N/A | ||
|
Forward Ventures Services LLC (Forward Ventures) | United States | +1 (858) 677-6077 | Series A | |||
|
Lilly Ventures | United States | +1 (317) 651-3050 | Series A | |||
|
Novo A/S | Denmark | Series A | ||||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | United States | Acquisition | |||
|
ProQuest Investments | United States | +1 (858) 847-0315 | Series A | |||
|
RBC Capital Partners | Canada | Series A | ||||
|
RiverVest Venture Partners (RiverVest Ventures) | United States | +1 (216) 658-3982 | Series A | |||
|
SR One Ltd | The venture capital unit of GlaxoSmithKline | United States | +1 (610) 567-1000 | Series A |